Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.
about
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and childrenAsthma phenotypes: the intriguing selective intervention with MontelukastRecent advances in the management of asthma using leukotriene modifiersTreatment of exercise-induced asthma, respiratory and allergic disorders in sports and the relationship to doping: Part II of the report from the Joint Task Force of European Respiratory Society (ERS) and European Academy of Allergy and Clinical ImmLipid Mediators of Allergic Disease: Pathways, Treatments, and Emerging Therapeutic TargetsAntileukotriene agents for the treatment of lung diseaseNewer Perspectives of Childhood AsthmaLeukotriene receptor antagonists: efficacy and safety in children with asthma.Montelukast: data from clinical trials in the management of asthma.New perspectives for asthma treatment: anti-leukotriene drugs.Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell functionPharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist.Asthma--the changing face of drug therapy.Leukotriene receptor antagonist therapyReproducibility of the airway response to an exercise protocol standardized for intensity, duration, and inspired air conditions, in subjects with symptoms suggestive of asthma.Leukotriene inhibitors and non-steroidal therapies in the treatment of asthma.Antileukotrienes in asthma: present situation.Children with difficult asthma: a practical approach.Choices of therapy for exercise-induced asthma in children.Issues and challenges in pediatric asthma.The role of leukotriene receptor antagonists in the treatment of chronic asthma in childhood.Exercise-induced asthma: critical analysis of the protective role of montelukastIncrease in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitationSpotlight on montelukast in asthma in children 2 to 14 years of age.Leukotriene receptor antagonists--risks and benefits for use in paediatric asthma.An update of the leukotriene modulators for the treatment of asthma.Childhood asthma. Balancing efficacy and adherence for optimum management.Tolerability profiles of leukotriene receptor antagonists and long-acting beta2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma: a review.Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction.Exercise-induced bronchoconstriction: The effects of montelukast, a leukotriene receptor antagonist.Asthma control in adolescents: role of leukotriene inhibitors.Leukotriene modifiers in the treatment of asthma in children.Leukotriene pathway in sickle cell disease: a potential target for directed therapy.Treatment options for the management of exercise-induced asthma and bronchoconstriction.Role of leukotriene receptor antagonists in the management of pediatric asthma: an update.Impact of montelukast on asthma associated with rhinitis, and other triggers and co-morbidities.Montelukast, current indications and prospective future applications.Pharmacotherapy for exercise-induced asthma: allowing normal levels of activity and sport.Air quality and temperature effects on exercise-induced bronchoconstriction.
P2860
Q24197682-A85CE536-D672-4ED9-AD3D-555F3DEAAAA6Q28071735-30274BBE-586A-458C-BC7F-1ACF1E7D4B5DQ28166742-A50CC515-DC7A-435C-B960-145B037CC253Q28275393-A1C5125C-1F60-42C8-B824-F6F692D25DEDQ28276574-08AD10BC-F796-4A75-8628-D1F5B9022B6BQ28293842-30C4AA68-B20D-4744-8EAB-F848F8FB4586Q28397893-1A08C57B-229B-4AF8-B530-27068C410B1CQ31420368-C07F5D13-BA90-4949-BC7A-A130B2E5F286Q31448541-D90B5B10-9EE0-41CD-A627-DA485F3485E6Q33729339-B93F0BCA-EAF5-48D9-9F6E-406E320C4B87Q33757657-47AD4B22-47DE-417E-81FB-C3D8B54F049DQ33805187-4B18EA83-AB4F-423F-941C-12EB7B0A355CQ33836674-B6606441-1A9B-49CF-BED5-178E54B8281AQ33930453-A0F0DCD3-ABF4-430E-BFBA-3008A0C6F200Q34086351-E32F0B3B-4E9A-4AEB-BDEC-9D0F2C908D4BQ34128467-37620044-6BFA-4A54-9753-A4233BE7D3F6Q34240729-FC093E87-3E96-4589-9490-6C4697F56C2FQ34240893-06757C4F-4543-4538-B925-BFC05082F1CFQ34273468-24B98A96-1CF7-4F36-A519-1DFBEF5C2698Q34291192-561C1F84-A3F8-463E-80EC-B14B4A12CEC5Q34291198-9C28F302-990F-4AB9-B27A-7684AEABDB59Q34291204-ACB361E0-92C7-4E77-B158-61726CEC674FQ34623842-9E928A97-6B39-4A79-A096-CB072D5610F1Q35536504-2BD041AD-4EB0-4CB0-ABD8-BACE45FEF9BAQ35627867-4FCDE183-7304-4187-8744-4F5D2CC4D82AQ35779312-E782B543-51C0-4726-9D8B-AFF1AC10B9C6Q35814442-FE2894C1-9005-4671-B385-E416495B4A1CQ36275342-1AB1792F-6C65-44E1-87B7-403109D2BB51Q36892408-8FBADE41-3024-4615-B3DE-40ACF2590DBBQ36916936-C5239058-D0CC-46DB-BCD8-A21BEFD42B41Q37462963-39AD6378-A862-45AF-B629-F6CCDC027135Q37561894-01076902-63D9-49A1-9186-D023E85EBDA1Q37613312-B2B937F3-20C8-4371-80D9-788DAD773ACFQ37810108-CB04415B-472C-45CF-828A-6806BD10D4E2Q37819748-7D7105AD-A1ED-481D-8038-3CBC67FFDA8AQ38034994-2CFA44F1-B79F-4DA4-9547-82127E340ECBQ38120057-3CFDCB45-7423-4FDD-8923-62393EAD9A37Q38835130-47B7E5DD-400B-4742-8697-74A2428D40EEQ39914397-211C682C-0B7E-4653-A0C0-587D68F694D9Q40272925-10584AFE-B390-4A92-AFAB-6ED1F05E77E6
P2860
Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Montelukast once daily inhibit ...... year-old children with asthma.
@en
Montelukast once daily inhibit ...... year-old children with asthma.
@nl
type
label
Montelukast once daily inhibit ...... year-old children with asthma.
@en
Montelukast once daily inhibit ...... year-old children with asthma.
@nl
prefLabel
Montelukast once daily inhibit ...... year-old children with asthma.
@en
Montelukast once daily inhibit ...... year-old children with asthma.
@nl
P2093
P1476
Montelukast once daily inhibit ...... year-old children with asthma.
@en
P2093
Dockhorn RJ
Seidenberg BC
Shapiro GG
P304
P356
10.1016/S0022-3476(98)70281-1
P407
P577
1998-09-01T00:00:00Z